Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 161-170 of 684 for cancer

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Testing The Addition Of An Anti-Cancer Drug, Cabozantinib To The Immunotherapy Drug Cemiplimab (REGN2810), In Adolescents And Adults With Advanced Adrenocortical Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. A Study To Investigate Subcutaneous Isatuximab In Combination With Weekly Carfilzomib And Dexamethasone In Adult Participants With Relapsed And/or Refractory Multiple Myeloma (SubQSA)

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  3. Reishi Mushroom Extract For Fatigue And/or Arthralgias/Myalgias In Patients With Breast Cancer On Aromatase Inhibitors

    Albert Lea, MN, Mankato, MN, Rochester, MN

  4. A Global Phase III Study Of Rilvegostomig Or Pembrolizumab Plus Chemotherapy For First-Line Treatment Of Locally Advanced Or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

    Jacksonville, FL, Rochester, MN

  5. Study Of The Theranostic Pair RYZ811 (Diagnostic) And RYZ801 (Therapeutic) To Identify And Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. A Study Of Tucatinib With Trastuzumab And MFOLFOX6 Versus Standard Of Care Treatment In First-line HER2+ Metastatic Colorectal Cancer (MOUNTAINEER-03)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. Hypofractionated Radiotherapy With Folfox For Esophageal/Gej Adenocarcinoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. MC1733, Phase I Trial Of Intratumoral Administration Of A Measles Virus Derivative Expressing The Helicobacter Pylori Neutrophil-activating Protein (NAP) (MV-s-NAP) In Patients With Metastatic Breast Cancer

    Rochester, MN

  9. VS-6766+Abema+Fulv In Met HR+/​HER- BC

    Rochester, MN

  10. Adding The Immunotherapy Drug Cemiplimab To Usual Treatment For People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy And Immunotherapy (An Expanded Lung-MAP Treatment Trial)

    Rochester, MN

.

Mayo Clinic Footer